NNC 63-0532

From WikiMD's Wellness Encyclopedia

NNC 63-0532‏‎ is a chemical compound that belongs to the class of benzodiazepine drugs. It is a potent and selective agonist for the GABA_A receptor, which is a major inhibitory neurotransmitter receptor in the brain. NNC 63-0532‏‎ has been used in scientific research to study the function and pharmacology of GABA_A receptors.

Chemistry[edit | edit source]

NNC 63-0532‏‎ is a benzodiazepine, a class of drugs that are typically characterized by a core benzene ring fused to a diazepine ring. Like other benzodiazepines, NNC 63-0532‏‎ has a heterocyclic structure, meaning it contains atoms of at least two different elements in its rings.

Pharmacology[edit | edit source]

NNC 63-0532‏‎ acts as an agonist at the GABA_A receptor, meaning it binds to this receptor and activates it. The GABA_A receptor is an ionotropic receptor that, when activated, allows negatively charged chloride ions to enter the neuron, making it more difficult for the neuron to generate an action potential and thus inhibiting its activity.

Research Use[edit | edit source]

Due to its potent and selective action on the GABA_A receptor, NNC 63-0532‏‎ has been used in scientific research to study the function and pharmacology of this receptor. It has been particularly useful in studies investigating the role of GABA_A receptors in anxiety, sleep disorders, and epilepsy.

See Also[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD